{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:15:27Z","timestamp":1783102527077,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022AF8KZ3"],"award-info":[{"award-number":["2022AF8KZ3"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Government of Italy Ministry of Education University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpba.2026.117576","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T06:49:30Z","timestamp":1779518970000},"page":"117576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic development and optimization of a cIEF method for the charge variants analysis of moderately basic to basic monoclonal antibodies using the Analytical Quality by Design strategy"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2168-8613","authenticated-orcid":false,"given":"Lucrezia","family":"Floris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-4062","authenticated-orcid":false,"given":"Benedetta","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6000-5079","authenticated-orcid":false,"given":"Serena","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1362-2808","authenticated-orcid":false,"given":"Francesca","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3035-9076","authenticated-orcid":false,"given":"Gabriella","family":"Massolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-1741","authenticated-orcid":false,"given":"Sandra","family":"Furlanetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-2248","authenticated-orcid":false,"given":"Roberto","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117576_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.biologicals.2016.06.005","article-title":"Determination of critical quality attributes for monoclonal antibodies using quality by design principles","volume":"44","author":"Alt","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.jpba.2026.117576_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2019.05.014","article-title":"Insights from capillary electrophoresis approaches for characterization of monoclonal antibodies and antibody drug conjugates in the period 2016\u20132018","volume":"1122-1123","author":"Lechner","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117576_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pmic.201200378","article-title":"Capillary electrophoresis and isoelectric focusing in peptide and protein analysis","volume":"13","author":"Righetti","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.jpba.2026.117576_bib4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/elps.201800079","article-title":"Determination of protein charge variants with (imaged) capillary isoelectric focusing and capillary zone electrophoresis","volume":"39","author":"Kahle","year":"2018","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115089","article-title":"Advances and applications of capillary electromigration methods in the analysis of therapeutic and diagnostic recombinant proteins \u2013 A Review","volume":"222","author":"Stutz","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117576_bib6","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1002\/elps.200800690","article-title":"A systematic study in CIEF: Defining and optimizing experimental parameters critical to method reproducibility and robustness","volume":"30","author":"Mack","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/elps.201300471","article-title":"Charge profiling and stability testing of biosimilar by capillary isoelectric focusing","volume":"35","author":"Cao","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib8","series-title":"Pharmaceutical Experimental Design","article-title":"Boca Raton","author":"Lewis","year":"1998"},{"key":"10.1016\/j.jpba.2026.117576_bib9","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/elps.201900162","article-title":"Design of experiments as a valuable tool for biopharmaceutical analysis with (imaged) capillary isoelectric focusing","volume":"40","author":"Kahle","year":"2019","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib10","unstructured":"ICH Harmonised Tripartite Guideline. Analytical procedure development Q14. 2023. Available at: \u3008https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1130_ErrorCorrection_2025.pdf\u3009. Accessed 5 Mar 2026."},{"key":"10.1016\/j.jpba.2026.117576_bib11","unstructured":"ICH Harmonised Tripartite Guideline. Quality risk management Q9(R1). 2023. Available at: \u3008https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q9%28R1%29_Guideline_Step4_2025_0115_0.pdf\u3009 Accessed 5 Mar 2026."},{"key":"10.1016\/j.jpba.2026.117576_bib12","unstructured":"ICH Guideline Q2 (R2), Validation of Analytical Procedures, 2022. \u3008https:\/\/database.ich.org\/sites\/default\/files\/Q2R2-Q14_EWG_Concept_Paper.pdf\u3009 Accessed 5 Mar 2026."},{"key":"10.1016\/j.jpba.2026.117576_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1208\/s12248-025-01178-8","article-title":"A Design of Experiments and Risk Management-Driven Analytical Platform for Charge Variant Analysis of Therapeutic Antibodies by Imaged Capillary Isoelectric Focusing","volume":"28","author":"Ghizzani","year":"2026","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2026.117576_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122485","article-title":"Isolation and characterization of charge variants of infliximab biosimilar HS626","volume":"1162","author":"Yuan","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117576_bib15","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/acs.analchem.7b04608","article-title":"Capillary isoelectric focusing-mass spectrometry method for the separation and online characterization of intact monoclonal antibody charge variants","volume":"90","author":"Dai","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117576_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jchromb.2016.05.028","article-title":"Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products","volume":"1032","author":"Gahoual","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117576_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jpba.2019.05.058","article-title":"Comparative charge-based separation study with various capillary electrophoresis (CE) modes and cation exchange chromatography (CEX) for the analysis of monoclonal antibodies","volume":"174","author":"Kahlea","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117576_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2537116","article-title":"Ion-exchange chromatography, capillary isoelectric focusing, and capillary zone electrophoresis coupled to mass spectrometry for charge variant analysis of monoclonal antibodies","volume":"17","author":"Schairer","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2026.117576_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107297","article-title":"Development and validation of an optimized and horizontal imaged capillary isoelectric focusing method for mAbs charge heterogeneity analysis","volume":"214","author":"Ghizzani","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117576_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.129346","article-title":"Analytical quality by design in the development of a paper-based microfluidic device for iron (II) determination as an impurity in iron (III) pharmaceuticals","volume":"301","author":"Waqar","year":"2026","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2026.117576_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/separations8010004","article-title":"Analysis of monoclonal antibodies by capillary electrophoresis: sample preparation, separation, and detection","volume":"8","author":"Dadouch","year":"2021","journal-title":"Separations"},{"key":"10.1016\/j.jpba.2026.117576_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1208\/s12248-026-01206-1","article-title":"Best practices for performing analytical and functional biosimilarity assessment of recombinant monoclonal antibody biosimilars","volume":"28","author":"Rathore","year":"2026","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2026.117576_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jpba.2015.04.037","article-title":"Capillary isoelectric focusing method development and validation for investigation of recombinant therapeutic monoclonal antibody","volume":"114","author":"Suba","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117576_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ab.2014.08.004","article-title":"Capillary isoelectric focusing of a difficult-to-denature tetrameric enzyme using alkylurea\u2013urea mixtures","volume":"465","author":"Gervais","year":"2014","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2026.117576_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2017.08.014","article-title":"Imaged capillary isoelectric focusing in native condition: A novel and successful example","volume":"537","author":"Zhang","year":"2017","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2026.117576_bib26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/elps.202000013","article-title":"Intact and middle-down CIEF of commercial therapeutic monoclonal antibody products under non-denaturing conditions","volume":"41","author":"Schmailzl","year":"2020","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib27","article-title":"Imaged capillary isoelectric focusing employing fluorocarbon and methylcellulose coated fused silica capillary for characterization of charge heterogeneity of protein biopharmaceuticals","volume":"6","author":"Kwok","year":"2023","journal-title":"Sep. Sci."},{"key":"10.1016\/j.jpba.2026.117576_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2025.1536222","article-title":"Exploring imaged capillary isoelectric focusing parameters for enhanced charge variants quality control","volume":"13","author":"Ghizzani","year":"2025","journal-title":"Front. Chem."},{"key":"10.1016\/j.jpba.2026.117576_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79108-5","article-title":"A new paradigm for optimized experimental design in cIEF platforms aimed at an accurate robust and reliable mAbs charge-variant assessment","volume":"14","author":"Belfiore","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2026.117576_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/elps.202300170","article-title":"CE methods for charge variant analysis of mAbs and complex format biotherapeutics","volume":"45","author":"Meudt","year":"2024","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2025.118212","article-title":"Recent developments of imaged capillary isoelectric focusing technology for in-depth biopharmaceutical characterization","volume":"187","author":"Bo","year":"2025","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117576_bib32","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/elps.200305978","article-title":"Capillary isoelectric focusing \u2013 reproducibility and protein adsorption","volume":"25","author":"Graf","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2026.117576_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/acs.analchem.4c05010","article-title":"Capillary Isoelectric Focusing of Proteins and Peptides Using an InLine cIEF-ESI Interface with Improved MS Characterist","volume":"97","author":"Kerr","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117576_bib34","unstructured":"European Pharmacopoeia, Council of Europe, 2025. Strasbourg, Current edition, general text 2.5.44 \u201ccapillary isoelectric focusing for recombinant therapeutic monoclonal antibodies\u201d. Available at \u3008https:\/\/pheur.edqm.eu\/app\/11-8\/content\/11-8\/20544E.ht\u3009 m?highlight=on&terms%5B%5D=2.5.44."},{"key":"10.1016\/j.jpba.2026.117576_bib35","series-title":"Models, and the Analysis of Mixture Data","article-title":"Experiments with Mixtures: Designs","author":"Cornell","year":"2002"},{"key":"10.1016\/j.jpba.2026.117576_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.chemolab.2005.04.010","article-title":"Estimation of the uncertainty of indirect measurements from the propagation of distributions by using the Monte-Carlo method: an overview","volume":"79","author":"Herrador","year":"2005","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.jpba.2026.117576_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2017.09.033","article-title":"Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies","volume":"1065-1066","author":"Goyon","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117576_bib38","unstructured":"J. Biddlecombe, J. Main, Du, M. Albarghouthi, Formulations of human anti-PD-L1 antibodies. WO Patent 2019\/206987 A1. October 31, 2019."},{"key":"10.1016\/j.jpba.2026.117576_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/pharmaceutics18030383","article-title":"Analytical physicochemical and functional studies to compare AryoTrust, a follow-on biologics, with the originator Trastuzumab (Herceptin)","volume":"18","author":"Al-Kinani","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2026.117576_bib40","first-page":"516","article-title":"Comparative analytical profiling of bevacizumab biosimilars marketed in India: a national control laboratory study","volume":"10","author":"Prakash","year":"2020","journal-title":"3Biotech"},{"key":"10.1016\/j.jpba.2026.117576_bib41","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1021\/acs.analchem.2c05071","article-title":"Mass spectrometry-based charge heterogeneity characterization of therapeutic mAbs with imaged capillary isoelectric focusing and ion-exchange chromatography as separation techniques","volume":"95","author":"Wu","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2026.117576_bib42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10337-011-2017-3","article-title":"Intercompany study to evaluate the robustness of capillary isoelectric focusing technology for the analysis of monoclonal antibodies","volume":"73","author":"Salas-Solano","year":"2011","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2026.117576_bib43","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/jssc.201200633","article-title":"Robustness of iCIEF methodology for the analysis of monoclonal antibodies: An interlaboratory study","volume":"35","author":"Salas-Solano","year":"2012","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2026.117576_bib44","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/elps.202100348","article-title":"Global intercompany assessment of iCIEF platform comparability for the characterization of therapeutic proteins","volume":"43","author":"Madren","year":"2022","journal-title":"Electrophoresis"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852600244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852600244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:17:23Z","timestamp":1783099043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852600244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S073170852600244X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117576","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic development and optimization of a cIEF method for the charge variants analysis of moderately basic to basic monoclonal antibodies using the Analytical Quality by Design strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117576"}}